-
461
Triglycerides mediate the relationships of per- and poly-fluoroalkyl substance (PFAS) exposure with nonalcoholic fatty liver disease (NAFLD) risk in US participants
Published 2025-01-01Subjects: “…Nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
462
Yogurt-derived Lactobacillus plantarum Q16 alleviated high-fat diet-induced non-alcoholic fatty liver disease in mice
Published 2022-09-01Subjects: “…Non-alcoholic fatty acid liver disease…”
Get full text
Article -
463
From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
Published 2025-01-01Subjects: “…Metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
464
Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
Published 2025-01-01“…BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for type 2 diabetes mellitus (T2DM), and its early identification and intervention offer opportunities for reversing diabetes mellitus.MethodsIn this study, we identified biomarkers for the MASLD dataset (GSE33814, GSE48452) and the T2DM dataset (GSE76895 and GSE89120) by bioinformatics analysis. …”
Get full text
Article -
465
Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
Published 2018-01-01“…The aim of this study was to appraise the relationship between serum fragmented cytokeratin-18(CK-18), controlled attenuation parameter (CAP), and liver steatosis assessed by ultrasound (US) in nonalcoholic fatty liver disease (NAFLD) patients. Methods. Patients who underwent abdominal US were recruited, followed with measurement of CAP using Fibroscan® and serum fragmented CK-18 using enzyme-linked immunosorbent assay. …”
Get full text
Article -
466
A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease
Published 2020-01-01“…Erzhi pill (EZP), a classical traditional Chinese medicine prescription, exerts a potent hepatoprotective effect against metabolic dysfunction-associated fatty liver disease (MAFLD), previously known as nonalcoholic fatty liver disease (NAFLD). …”
Get full text
Article -
467
Radiofrequency Energy in Hepatic Bed during Partial Cystectomy for Hydatid Liver Disease: Standing Out from the Usual Conservative Surgical Management
Published 2016-01-01“…Surgical treatment of hydatid liver disease (HLD) is divided into conservative and radical procedures. …”
Get full text
Article -
468
Single-cell Profiling of Intrahepatic Immune Cells Reveals an Expansion of Tissue-resident Cytotoxic CD4+ T Lymphocyte Subset Associated With Pathogenesis of Alcoholic-associated Liver DiseasesSummary
Published 2025-01-01Subjects: “…Alcoholic-associated Liver Disease…”
Get full text
Article -
469
PLEYOTROPIC EFFECTS OF METFORMIN
Published 2015-01-01Subjects: “…nonalcoholic fatty liver disease…”
Get full text
Article -
470
RECURRENCE OF BREAST CANCER AFTER SUBCUTANEOUS MASTECTOMY WITH SIMULTANEOUS RECONSTRUCTION
Published 2015-01-01Subjects: “…nonalcoholic fatty liver disease…”
Get full text
Article -
471
The immunoregulatory effects of scoparone on immune-mediated inflammatory diseases
Published 2025-01-01Subjects: Get full text
Article -
472
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
Published 2025-01-01Subjects: “…Metabolic dysfunction associated steatotic liver disease (MASLD)…”
Get full text
Article -
473
Assessing the diagnostic accuracy of radiological and histological findings in the diagnosis of non-alcoholic fatty liver disease stages among patients in a tertiary hospital
Published 2024-07-01“…Aim and Objectives: To evaluate the diagnostic strength of ultrasound in the diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD) stages. Material and Methods: Participants were recruited from patients with fatty liver who underwent liver biopsy and baseline ultrasound at the University of Calabar Teaching Hospital between January 2023 and December 2023. …”
Get full text
Article -
474
The Counteracting Effect of Chrysin on Dietary Fructose-Induced Metabolic-Associated Fatty Liver Disease (MAFLD) in Rats with a Focus on Glucose and Lipid Metabolism
Published 2025-01-01“…We explored the effect of chrysin, a dietary polyphenol, on hepatic lipid and glycogen accumulation, metabolic dysfunction-associated fatty liver disease (MAFLD) activity score and oxidative stress and on hepatic and adipose tissue metabolism in rats presenting metabolic syndrome-associated conditions. …”
Get full text
Article -
475
An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
Published 2020-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
476
Estimation of Apolipoprotein A1, Haptoglobin and Alpha 2macroglobulin with some Biochemical Metabolic Markers in Nonalcoholic Fatty Liver Disease Iraqi Patients
Published 2021-03-01Subjects: “…nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
477
Ethyl Lactate Ameliorates Hepatic Steatosis and Acute‐on‐Chronic Liver Injury in Alcohol‐Associated Liver Disease by Inducing Fibroblast Growth Factor 21
Published 2025-02-01Subjects: “…alcohol‐associated liver disease…”
Get full text
Article -
478
Nonalcoholic Fatty Liver Disease as a Potential Risk Factor for Cardiovascular Disease in Patients with Type 2 Diabetes: A Prospective Cohort Study
Published 2024-01-01“…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder in western countries. …”
Get full text
Article -
479
Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion
Published 2017-01-01“…Nonalcoholic fatty liver disease (NAFLD) has become a leading cause of liver transplantation. …”
Get full text
Article -
480
Non-alcoholic fatty liver disease (NAFLD): A comparative study of clinico-socio-demographic characteristics among two diverse Indian population
Published 2024-09-01“…The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing not only in India but also globally. …”
Get full text
Article